参天製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/03/18 | 1,322 | 1,328 | 1,307 | 1,323 | +13 | +1% | 1,838,100 |
| 2022/03/17 | 1,341 | 1,341 | 1,309 | 1,310 | -3 | -0.2% | 1,651,300 |
| 2022/03/16 | 1,309 | 1,326 | 1,309 | 1,313 | +28 | +2.2% | 1,782,900 |
| 2022/03/15 | 1,246 | 1,290 | 1,246 | 1,285 | +39 | +3.1% | 1,164,300 |
| 2022/03/14 | 1,260 | 1,270 | 1,245 | 1,246 | -3 | -0.2% | 727,800 |
| 2022/03/11 | 1,271 | 1,273 | 1,243 | 1,249 | -19 | -1.5% | 1,609,300 |
| 2022/03/10 | 1,261 | 1,274 | 1,249 | 1,268 | +44 | +3.6% | 1,260,500 |
| 2022/03/09 | 1,217 | 1,234 | 1,210 | 1,224 | -12 | -1% | 1,036,800 |
| 2022/03/08 | 1,222 | 1,253 | 1,222 | 1,236 | +5 | +0.4% | 1,513,300 |
| 2022/03/07 | 1,235 | 1,238 | 1,215 | 1,231 | -15 | -1.2% | 1,403,800 |
| 2022/03/04 | 1,255 | 1,261 | 1,240 | 1,246 | -22 | -1.7% | 1,330,800 |
| 2022/03/03 | 1,269 | 1,270 | 1,251 | 1,268 | +9 | +0.7% | 878,800 |
| 2022/03/02 | 1,275 | 1,287 | 1,258 | 1,259 | -32 | -2.5% | 795,000 |
| 2022/03/01 | 1,304 | 1,315 | 1,291 | 1,291 | -13 | -1% | 935,800 |
| 2022/02/28 | 1,273 | 1,307 | 1,266 | 1,304 | +37 | +2.9% | 2,395,900 |
| 2022/02/25 | 1,254 | 1,275 | 1,250 | 1,267 | +20 | +1.6% | 1,282,300 |
| 2022/02/24 | 1,260 | 1,263 | 1,237 | 1,247 | -27 | -2.1% | 1,528,500 |
| 2022/02/22 | 1,281 | 1,286 | 1,265 | 1,274 | -10 | -0.8% | 992,000 |
| 2022/02/21 | 1,277 | 1,293 | 1,271 | 1,284 | -21 | -1.6% | 704,800 |
| 2022/02/18 | 1,275 | 1,311 | 1,274 | 1,305 | +12 | +0.9% | 876,400 |
| 2022/02/17 | 1,305 | 1,307 | 1,289 | 1,293 | -17 | -1.3% | 1,096,300 |
| 2022/02/16 | 1,315 | 1,324 | 1,302 | 1,310 | +6 | +0.5% | 1,132,600 |
| 2022/02/15 | 1,290 | 1,310 | 1,286 | 1,304 | +15 | +1.2% | 1,067,400 |
| 2022/02/14 | 1,303 | 1,313 | 1,283 | 1,289 | -45 | -3.4% | 1,948,700 |
| 2022/02/10 | 1,365 | 1,369 | 1,320 | 1,334 | -3 | -0.2% | 1,812,600 |
| 2022/02/09 | 1,333 | 1,348 | 1,322 | 1,337 | +9 | +0.7% | 846,600 |
| 2022/02/08 | 1,332 | 1,341 | 1,324 | 1,328 | +7 | +0.5% | 835,700 |
| 2022/02/07 | 1,314 | 1,327 | 1,311 | 1,321 | +2 | +0.2% | 651,100 |
| 2022/02/04 | 1,305 | 1,325 | 1,302 | 1,319 | +19 | +1.5% | 1,253,200 |
| 2022/02/03 | 1,291 | 1,305 | 1,287 | 1,300 | -7 | -0.5% | 1,151,600 |
| 2022/02/02 | 1,293 | 1,315 | 1,293 | 1,307 | +20 | +1.6% | 1,531,600 |
| 2022/02/01 | 1,313 | 1,313 | 1,287 | 1,287 | -10 | -0.8% | 1,239,300 |
| 2022/01/31 | 1,289 | 1,306 | 1,277 | 1,297 | +15 | +1.2% | 1,197,000 |
| 2022/01/28 | 1,274 | 1,285 | 1,267 | 1,282 | +4 | +0.3% | 1,578,000 |
| 2022/01/27 | 1,308 | 1,315 | 1,266 | 1,278 | -46 | -3.5% | 1,477,100 |
| 2022/01/26 | 1,327 | 1,332 | 1,308 | 1,324 | -10 | -0.7% | 1,087,900 |
| 2022/01/25 | 1,318 | 1,335 | 1,305 | 1,334 | +7 | +0.5% | 1,054,600 |
| 2022/01/24 | 1,284 | 1,327 | 1,283 | 1,327 | +38 | +2.9% | 1,474,000 |
| 2022/01/21 | 1,299 | 1,300 | 1,275 | 1,289 | -16 | -1.2% | 1,901,100 |
| 2022/01/20 | 1,301 | 1,320 | 1,300 | 1,305 | +4 | +0.3% | 1,595,500 |
| 2022/01/19 | 1,330 | 1,338 | 1,298 | 1,301 | -42 | -3.1% | 1,486,900 |
| 2022/01/18 | 1,380 | 1,383 | 1,340 | 1,343 | -37 | -2.7% | 1,530,700 |
| 2022/01/17 | 1,389 | 1,395 | 1,370 | 1,380 | -6 | -0.4% | 670,200 |
| 2022/01/14 | 1,403 | 1,414 | 1,378 | 1,386 | -46 | -3.2% | 1,602,200 |
| 2022/01/13 | 1,460 | 1,463 | 1,431 | 1,432 | -7 | -0.5% | 1,270,100 |
| 2022/01/12 | 1,437 | 1,457 | 1,435 | 1,439 | +12 | +0.8% | 1,396,200 |
| 2022/01/11 | 1,423 | 1,432 | 1,408 | 1,427 | +18 | +1.3% | 1,158,200 |
| 2022/01/07 | 1,417 | 1,425 | 1,401 | 1,409 | -6 | -0.4% | 854,800 |
| 2022/01/06 | 1,410 | 1,432 | 1,409 | 1,415 | -7 | -0.5% | 919,800 |
| 2022/01/05 | 1,421 | 1,431 | 1,416 | 1,422 | -10 | -0.7% | 1,074,600 |
751～
800
件表示中 / 3678件
類似銘柄と比較する
現在ご覧いただいている「参天薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 参天薬 | 131,400円 | 0.0% | +50.6% | 2.74% | 13.80倍 | 1.55倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| 小野薬 | 162,700円 | -3.5% | -50.2% | 4.92% | 13.18倍 | 0.98倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
| ロート | 234,200円 | +18.2% | +4.2% | 1.54% | 16.44倍 | 2.09倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
| 久光薬 | 428,800円 | +5.8% | +1.2% | 2.80% | 14.22倍 | 1.13倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| ツムラ | 406,900円 | +20.9% | +87.3% | 3.34% | 9.09倍 | 1.05倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム
